- Gene Changes Linked to Most Common Form of Melanoma
- Medarex Announces FDA Fast Track Designations for Ipilimumab for the Treatment of Met
- Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Me
- Michigan and Stanford: Stem cell marker identified in head and neck cancer
- Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Mela
- Chemicals In Brown Algae May Protect Against Skin Cancer
- Melanoma Basics
- 'Guardian of the genome' protein found to underlie skin tanning
- Molecular differences between early and advanced melanomas could provide new drug tar
- Cellular 'SOS' signal in response to UV skin damage
- Reversing cancer cells to normal cells
- New survey ranks the nation's most and least sun-smart cities
- Stanford researchers identify immune dysfunction in melanoma patients
- Caspase-14 protects our skin against UVB and dehydration
- Sun exposure early in life linked to specific skin cancer gene mutation
- Why moles can become skin cancers
- A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
- Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherap
- The good anthrax
- Multiple skin cancer risk behaviors are common among US adults
- Natural secretion marks difference between mole and melanoma
- Genome-wide survey nets key melanoma gene
- Embryonic Stem Cell Protein Inhibits Melanoma
- Teenage girls aren't the only ones who tan indoors -- older adults do so as well
- Calorie restriction inhibits, obesity fuels development of epithelial cancers
- The evolving stem cell story. Will we live a thousand years?
- Melanoma lurks in larger skin lesions, NYU researchers find
- Scientists identify interacting proteins key to melanoma development, treatment
- Skin flaps deliver cancer-fighting therapy, ASPS study reveals
- U of Minnesota researcher discovers the starting point of sun-induced skin cancer
- Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
- Novel enzyme inhibitor paves way for new cancer drug
- New combination therapy safe, promising for melanoma patients
- Inherited melanoma risk: What you do know does help you
- Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remis
- NYU researchers demonstrate activity of mebendazole in metastatic melanoma
- History of nonmelanoma skin cancer is associated with increased risk for subsequent m
- Gene required for radiation-induced protective pigmentation also promotes survival of
- Resident physicians seldom trained in skin cancer examination
- Melanoma treatment options 1 step closer
- New Paradigms of Cancer Treatment
- Celebrex may help prevent some non-melanoma skin cancers
- Arthritis medication has anti skin cancer effects
- A new high-resolution method for imaging below the skin using a liquid lens
- PARP Inhibitors for Melanoma?
- Chemosensitivity Testing in soft tissue sarcomas
- Vemurafenib approved by the FDA for metastatic melanoma
- Skin metastases from lung cancer
- Virotherapy
- VEGF Helps Renew Stem Cells In Skin Cancer
- Skin metastases from ovarian cancer
- Skin Tumors Induced by Nexavar (Sorafenib)
- FDA Approves Erivedge for Skin Cancer
- Natural compound in broccoli could treat devastating genetic skin disorder
- FDA Staff Questions Benefits of Sarcoma Cancer Drugs
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- How Cancers Spread At A Cellular Level
- Scientists discover melanoma-driving genetic changes caused by sun damage
- Skin Cancer Risk Increased by HPV Infection
- Adjuvant Systemic Treatment of Melanoma
- Mohs Surgery OK in Seniors Aged 90 Years or Older
- A Dermatologist Can Improve Melanoma Prognosis
- Why Some Cancer Vaccines Fail
- Aspirin May Reduce Melanoma Risk
- The Pathology in Treating Melanoma
- CT and serum LDH shows promise as survival predictor for some metastatic melanoma pat
- Virus kills melanoma in animal model, spares normal cells
- What all involved in Melanoma surgery?
- Phase 1 study: anti-PD-1 Nivolumab in combination with ipilimumab